ESOCAP

esocap-logo

EsoCap is the operator of a drug delivery platform designed for the treatment of diseases of the upper gastrointestinal tract. The company's technology offers targeted and long-lasting treatment of patients' esophageal mucosa using a capsule containing a thin film loaded with a drug, enabling patients with esophageal diseases to improve their lives.

#People #Website #More

ESOCAP

Social Links:

Industry:
Biotechnology

Founded:
2017-01-01

Address:
Basel, Basel-Stadt, Switzerland

Country:
Switzerland

Website Url:
http://www.esocapbiotech.ch

Total Employee:
1+

Status:
Active

Contact:
+41 61 515 0777

Email Addresses:
[email protected]


Current Employees Featured

werner-tschollar_image

Werner Tschollar
Werner Tschollar Founder and Chairman @ EsoCap
Founder and Chairman
2017-04-01

Official Site Inspections

http://www.esocapbiotech.ch

  • Host name: 158.181.214.35.bc.googleusercontent.com
  • IP address: 35.214.181.158
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "EsoCap"

Team - EsoCap Biotech

Our Team EsoCap AG is a Swiss privately held company led by one of the most experienced teams in the industry. Management Isabelle Racamier CEO and Board Director Patrick …See details»

EsoCap - Crunchbase Company Profile & Funding

EsoCap is the operator of a drug delivery platform designed for the treatment of diseases of the upper gastrointestinal tract. The company's technology offers targeted and long-lasting …See details»

EsoCap AG - LinkedIn

Dec 24, 2020 https://www.esocapbiotech.com External link for EsoCap AG. ... Basel, Basel-Town 4052, CH Get directions Employees at EsoCap AG Werner TSCHOLLAR Founder, CEO & President at AMYRA Biotech AG ...See details»

EsoCap AG - VentureRadar

Website: https://www.esocapbiotech.ch/ Develops innovative topical drug delivery solutions targeting upper gastrointestinal tract diseases for effective and targeted ...See details»

Scientific Platform - EsoCap Biotech

EsoCap Technology The Scientific Platform EsoCap owns a unique drug delivery platform allowing the topical application of drug substances for targeted and long-lasting treatment of diseases of the upper gastrointestinal tract for the first …See details»

EsoCap AG - Swiss Biotech

EsoCap AG is developing a unique targeted delivery platform technology for the treatment of patients with diseases of the esophagus. EsoCap recently successfully completed the double-blind, randomised, placebo-controlled …See details»

Esocap AG:Company Profile & Technical Research,Competitor …

Esocap AG is a company that provides Drug, Gastrointestinal tract, Herb and more. Esocap AG is headquartered in Switzerland Basel-Stadt. Esocap AG was founded in 2017.See details»

Esocap AG - Drug pipelines, Patents, Clinical trials - Synapse

Explore Esocap AG with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 3 news.See details»

EsoCap AG Overview | SignalHire Company Profile

EsoCap’s vision is to improve the lives of patients with serious illnesses through the development of a unique topical drug delivery platform for diseases of the upper gastrointestinal tract. The …See details»

EsoCap - Overview, News & Similar companies | ZoomInfo.com

Www.esocapbiotech.ch. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. Eosinophilic Esophagitis Market to Show Positive Growth by …See details»

EsoCap’s Competitors, Revenue, Number of Employees, Funding

EsoCap’s Profile, Revenue and Employees. EsoCap is a Switzerland-based biotechnology company that develops and commercializes novel therapies for the treatment of esophageal …See details»

EsoCap AG profile featured in Nature Biopharma Dealmakers

Jul 28, 2021 The feature in the latest issue of the renowned Nature Research publication gives an insightful overview of EsoCap’s company profile and the current development stage of their …See details»

EsoCap Company Profile 2024: Valuation, Funding & Investors

EsoCap General Information Description. Operator of a drug delivery platform designed for the treatment of diseases of the upper gastrointestinal tract. The company's technology offers …See details»

EsoCap AG - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for EsoCap AG of Basel, BASEL-STADT. Get the latest business insights from Dun & Bradstreet.See details»

EsoCap – unique targeted application platform to treat the

Sep 9, 2021 EsoCap’s targeted application technology drastically increases mucosal contact time and enables effective local treatment of various esophageal diseases for the first timeSee details»

Clinical Development - EsoCap Biotech

EsoCap Technology Clinical Development Our approach is to show the clinical proof of concept for our unique drug delivery technology in one indication and to seek for a major partner within …See details»

Solved Which organization issues Accounting Standards - Chegg

1 day ago Which organization issues Accounting Standards Updates (ASUs) to amend and improve the Accounting Standards Codification (ASC)?IASBPCAOBFASBGASB Your …See details»

EsoCap selected as a top biotech start-up by Life Sciences Review

Dec 28, 2021 EsoCap AG has been recognised by the special issue of Life Sciences Review Europe as a top biotech start-up. “We are extremely pleased to have been chosen for the …See details»

EsoCap secures new funding - EsoCap Biotech

Nov 18, 2021 EsoCap successfully closes a private financing round, with investments from existing and new investors The new funding was facilitated by EsoCap benefitting from a …See details»